Medicines, Poisons and Therapeutic Goods Regulation 2026
81Compliance standards for Opioid Treatment Program
Start here
Get a plain-English read of 81
Turn the raw legal text into a practical explanation grounded in Medicines, Poisons and Therapeutic Goods Regulation 2026.
81 Compliance standards for Opioid Treatment Program
81 Compliance standards for Opioid Treatment Program
(1) For the Act, section 74(4)(a), a person who supplies, administers or issues a prescription for buprenorphine or methadone under an OTP registration must carry out the activity in compliance with the OTP standards.
Maximum penalty—Tier 5 penalty.
(2) For the Act, section 74(4)(b), a pharmacist who dispenses buprenorphine or methadone at a pharmacy under an OTP registration must carry out the activity in compliance with the OTP standards.
Maximum penalty—Tier 5 penalty.
(3) For the Act, section 74(4)(c), a provider under the Opioid Treatment Program who is the holder of an obtain licence must ensure the OTP clinic is operated in compliance with the OTP standards.
Maximum penalty—Tier 5 penalty.
(4) For the Act, section 74(4)(d), a public health entity operating a public OTP clinic must ensure the OTP clinic is operated in compliance with the OTP standards.
Maximum penalty—Tier 5 penalty.
(5) For the Act, section 74(4)(d), a person carrying out an activity for which an OTP registration is not required under section 82 is prescribed and must carry out the activity in compliance with the provisions of the OTP standards specified in the OTP standards as applying to the person.
Maximum penalty—Tier 5 penalty.
(6) In this section—
OTP standards means the standards for compliance issued by the Health Secretary for the Act, section 74(4).